Domov › Rakovina prostaty › North Carolina › Durham
Klinické štúdie Rakovina prostaty v meste Durham, NC
32 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Durham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Duke University, Durham
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Prebieha náborFáza 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Prebieha náborFáza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Durham
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Prebieha náborFáza 1/2
- Duke University Medical Center, Durham
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prebieha náborFáza 3
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- a 1 ďalších
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Prebieha náborFáza 2
- Durham VA Medical Center, Durham, NC, Durham
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Prebieha náborFáza 2
- Durham VA Medical Center, Durham, NC, Durham
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 1
- Duke University Medical Center, Durham
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prebieha náborFáza 3
- Duke University Medical Center, Durham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- Durham VA Medical Center, Durham
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Prebieha náborObservačná štúdia
- Duke University, Durham
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- Duke University Medical Center, Durham
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Prebieha náborFáza 1/2
- Duke University medical center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Duke University, Durham
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Prebieha náborFáza 2
- Duke University Medical Center - Duke Cancer Center, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 1
- Duke Cancer Institute, Durham
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Prebieha náborObservačná štúdia
- Duke University, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Prebieha náborFáza 1
- Duke Cancer Center, Durham
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Prebieha náborFáza 1/2
- Duke University, Durham
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Prebieha náborVítaní zdravých dobrovoľníkov
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 míľ odtiaľ
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prebieha náborFáza 4
- Duke University Medical Center, Durham
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prebieha náborObservačná štúdia
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- Duke University, Durham
- a 1 ďalších
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prebieha náborFáza 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- Duke Cancer Institute, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prebieha náborFáza 1
- Duke Cancer Center, Durham
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Prebieha nábor
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 míľ odtiaľ
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Prebieha náborObservačná štúdia
- Duke University Medical Center, Durham
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN43 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Durham
- Rakovina prsníka64 štúdií
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc39 štúdií
- Mnohonásobný myelóm37 štúdií
- Akútna myeloidná leukémia33 štúdií
- Metastatická rakovina33 štúdií
- Rakovina pľúc32 štúdií
- Kolorektálny karcinóm28 štúdií
- Rakovina vaječníkov27 štúdií
- Chronická lymfocytová leukémia27 štúdií
- Srdcové zlyhanie26 štúdií
- Rakovina pankreasu24 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.